CencoraRegister for a premium account to gain access to Sterling AI.
Get StartedThings you can ask Sterling:
CencoraPharmaceutical distributor formerly AmerisourceBergen, renamed in 2023. FY2025 revenue rose 9.3% to $321.3B, growth the company attributes largely to higher-priced new therapies including the GLP-1 class; US Healthcare Solutions revenue specifically cites diabetes and weight-loss labelled products.
2021-Q2-2026-Q1
2021-Q2-2026-Q1
2001-2025
$COR
Formerly AmerisourceBergen, renamed in 2023. FY2025 revenue rose 9.3% to $321.3B, growth the company attributes largely to higher-priced new therapies including the GLP-1 class, with US Healthcare Solutions specifically citing products labelled for diabetes or weight loss.